Alnylam Pharmaceuticals Inc (ALNY)

264.47 -4.48 (-1.67%) USD  |  NASDAQ  |  Nov 13, 16:00
265.29 +0.82 (+0.31%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Annual Revenue Estimates Data

View and export this data back to 2022. Upgrade now.
Date Value
December 31, 2026 --
December 31, 2025 --
December 31, 2024 --
Date Value
December 31, 2023 --
December 31, 2022 --

Annual Revenue Estimates Range, Past 5 Years

Upgrade
Minimum
2022
Upgrade
Maximum
2026
Upgrade
Average
Upgrade
Median
2024

Annual Revenue Estimates Benchmarks

Pfizer Inc Upgrade
BridgeBio Pharma Inc Upgrade
Biomarin Pharmaceutical Inc Upgrade
Gilead Sciences Inc Upgrade
Regeneron Pharmaceuticals Inc Upgrade